down arrow

KPC Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000015P8
CNY
13.16
-2.49 (-15.91%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
KPC Pharmaceuticals, Inc.
Why is KPC Pharmaceuticals, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 1.01% and Operating profit at 15.09% over the last 5 years
2
With a fall in EPS of -30.39%, the company declared Very Negative results in Jun 25
  • INTEREST(HY) At CNY 27.47 MM has Grown at 108.62%
  • NET SALES(Q) At CNY 1,722.76 MM has Fallen at -14.69%
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,284.13
3
Below par performance in long term as well as near term
  • Along with generating -12.35% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is KPC Pharmaceuticals, Inc. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
KPC Pharmaceuticals, Inc.
-100.0%
-1.29
27.60%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.01%
EBIT Growth (5y)
15.09%
EBIT to Interest (avg)
15.66
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.18
Tax Ratio
20.51%
Dividend Payout Ratio
35.05%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.74%
ROE (avg)
10.11%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
2.04
EV to EBIT
11.37
EV to EBITDA
9.15
EV to Capital Employed
2.28
EV to Sales
1.19
PEG Ratio
0.21
Dividend Yield
2.13%
ROCE (Latest)
20.08%
ROE (Latest)
14.58%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(9M)

At CNY 451.9 MM has Grown at 60.61%

RAW MATERIAL COST(Y)

Fallen by -3.79% (YoY

CASH AND EQV(HY)

Highest at CNY 5,786.95 MM

-16What is not working for the Company
INTEREST(HY)

At CNY 27.47 MM has Grown at 108.62%

NET SALES(Q)

At CNY 1,722.76 MM has Fallen at -14.69%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,284.13

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.23%

PRE-TAX PROFIT(Q)

At CNY 148.5 MM has Fallen at -36.06%

NET PROFIT(Q)

At CNY 106.73 MM has Fallen at -30.42%

Here's what is working for KPC Pharmaceuticals, Inc.
Cash and Eqv
Highest at CNY 5,786.95 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -3.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for KPC Pharmaceuticals, Inc.
Interest
At CNY 27.47 MM has Grown at 108.62%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
At CNY 1,722.76 MM has Fallen at -14.69%
over average net sales of the previous four periods of CNY 2,019.41 MM
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio
Lowest at 1,284.13
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit
At CNY 148.5 MM has Fallen at -36.06%
over average net sales of the previous four periods of CNY 232.24 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit
At CNY 106.73 MM has Fallen at -30.42%
over average net sales of the previous four periods of CNY 153.39 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (CNY MM)

Debtors Turnover Ratio
Lowest at 2.23%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."